JOSEPH SHARPE: Open Payments
NPI 1508863929 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,152 in 26 payments from 10 companies in 2025. Trend: 2023 $4,878 · 2024 $472 · 2025 $15,152
Debt forgiveness: $14,203Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $14,203 |
| LivaNova USA, Inc. | 3 | $403 |
| Alkermes, Inc. | 9 | $185 |
| E.R. Squibb & Sons, L.L.C. | 2 | $145 |
| Lundbeck LLC | 3 | $69 |
| Corium, LLC | 3 | $62 |
| Vertical Pharmaceuticals, LLC | 2 | $34 |
| Tris Pharma Inc | 1 | $19 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, ARISTADA, COBENFY, REXULTI, Azstarys, Relexxii, Dyanavel XR.
Industry payments across TN — which companies pay providers there.
